Keyphrases
Multicenter Registry
100%
Japan
100%
COVID-19
100%
Inflammatory Bowel Disease
100%
Conductor-like Screening Model for Real Solvents (COSMO-RS)
100%
Disease Activity
27%
Severe Coronavirus Disease 2019
18%
High Body Mass Index
9%
Japanese Patients
9%
Disease Severity
9%
Risk Factors
9%
Stepwise Logistic Regression Analysis
9%
Clinical Course
9%
Non-severe
9%
Corticosteroids
9%
Cerebrovascular Disease
9%
Risk Reduction
9%
Severe Disease
9%
Disease Treatment
9%
World Health Organization Classification
9%
Anti-tumor Necrosis Factor Antibody
9%
Symptom Severity
9%
Severe Infection
9%
Clinical Remission
9%
Thiopurines
9%
Disease Classification
9%
Observational Cohort Study
9%
Coronavirus Impact
9%
Number of Deaths
9%
Classification Treatment
9%
Critical Disease
9%
Disease Factor
9%
Coronavirus Disease 2019 Outbreak
9%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
100%
Cohort Study
100%
Coronavirinae
100%
Diseases
100%
Disease Activity
18%
Combination Therapy
6%
Disease Course
6%
Infection
6%
Disease Severity
6%
Tumor Necrosis Factor Antibody
6%
Remission
6%
Cerebrovascular Disease
6%
Mercaptopurine
6%
Disease Classification
6%
Medicine and Dentistry
Inflammatory Bowel Disease
35%